New Clinical Trial Opportunity
A study is opening to approximately 60 participants for the investigation of a new topical medication for the prevention of basal cell carcinomas (BCCs) associated with Gorlin
This survey provides comprehensive information on the challenges the Gorlin syndrome community faces.
Gorlin syndrome (GS) is a rare autosomal dominant disease that affects approximately 1 in 31,000 individuals worldwide. GS is primarily associated with a mutation in the PTCH1, PTCH2,
Women with GS who had ovarian fibromas may be more susceptible to BCCs
Incidence of Gorlin Syndrome and Its Relation to Malignancy of the Skin in Gorlin Syndrome Patients Tiffany T. Wu, BA1; DeeA J. Pithadia, BS2; Joyce Teng, MD, PhD1 1Department of
For our health care providers: Why people with GS should limit exposure to X-rays and CT scans when possible.
Severe PATCHED1 Deficiency in Cancer-Prone Gorlin Patient Cells Results in Intrinsic Radiosensitivity Adeline Vulin, PhD,* Melissa Sedkaoui, MS,* Sandra Moratille,*
There may be improved long term outcome by use of 5-fluorouracil during surgery for jaw cysts (OKCs).
(This study did not include people affected with GS.) Marco F. Caminiti, DDS, MEd,* Mohamed El-Rabbany, DDS, MSc,y Justin Jeon, MSc,z and Grace Bradley, DDS, PHDx Purpose: The
Plaquenil Facts
Julie Breneiser, GSA’s Executive Director has provided great information! Plaquenil is a medication prescribed for the treatment of malaria, rheumatoid arthritis and lupus
COVID-19 AND GORLIN SYNDROME PATIENTS
At this time there is no evidence to suggest an interaction between the SARS-CoV-2 mRNA vaccines and Erivedge(r) [Vismodegib], nor other Gorlin syndrome manifestations. Clinical
Erivedge and COVID-19 Vaccines
Genentech, the pharmaceutical company that makes Erivedge (vismodegib) has supplied information to the Gorlin Syndrome Alliance regarding the safety of the COVID-19 vaccines that are
Report of FDA Gorlin Syndrome Patient-Led Listening Session 11/09/2020
Session Objectives: Educate the FDA staff on the complex issues of Gorlin syndrome (GS), both related to the basal cell carcinoma’s (BCCs) and the variety of physical manifestations
Virtual Patient Conference October 24 @ 11am Eastern
We are proud to announce our first virtual conference, “Forging New Paths to Find a Cure,” taking place on Saturday, October 24, 2020 from 11:00 am to 5:15 pm EST. Click here to